Approval · Notice of Compliance 27262 · 2021
GALAFOLD: Notice of Compliance 27262
Issued December 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27262
- Date
- December 16, 2021
- Company
- Amicus Therapeutics Uk Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph including revisions to the listing of amenable and non-amenable mutations Update the Product Monograph to 2020 format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GALAFOLD | Not yet assigned | — |
Medicinal ingredients
- MIGALASTAT HYDROCHLORIDE 123 MG per CAP